Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T17:15:25.644Z.
Calculation as of: 2026-10-06T17:15:25.644Z.
Quote observation: 2026-10-06T17:10:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b909c1583fef9061a4d716d1bfa7e8c39158eca830282836b9decd9e758125
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Akanda Corp.
Market Cap
$61819.00
Price/OCF Ratio
N/A
Market Cap
$30755.00
Price/OCF Ratio
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO |
|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30755.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95095.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108688.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6064.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
